TREATMENT OF METASTATIC STAGE PROSTATE CANCER WITH DEGARELIX

• 收藏
• 分享

专利权人:

FERRING INTERNATIONAL CENTER SA

发明人:

PERSSON, BO-ERIC

申请号：

NZ58708809

公开号：

NZ587088A

申请日:

2009.02.10

申请国别(地区):

NZ

年份:

2012

代理人:

摘要：

Disclosed is the use of a composition comprising degarelix in the manufacture of a medicament for the treatment of metastatic stage prostate cancer in a subject, wherein the subject has a baseline serum alkaline phosphatase (S-ALP) level of about 150IU/L or greater prior to treatment and wherein the subject shows a reduction below the baseline S-ALP level of at least 50IU/L. or greater for the period between about day 60 and day 364 of treatment.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/